Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site,Berlin, Germany,January–March 2021 |
| |
| Authors: | Welmoed van Loon,Heike Rö ssig,Susen Burock,Jö rg Hofmann,Julian Bernhard,Elisabeth Linzbach,Domenika Pettenkofer,Christian Schö nfeld,Maximilian Gertler,Joachim Seybold,Tobias Kurth,Frank P. Mockenhaupt |
| |
| Affiliation: | Charité–Universitätsmedizin Berlin, Berlin, Germany (W. van Loon, H. Rössig, S. Burock, J. Bernhard, E. Linzbach, D. Pettenkofer, C. Schönfeld, M. Gertler, J. Seybold, T. Kurth, F.P. Mockenhaupt);Labor Berlin–Charité Vivantes GmbH, Berlin (J. Hofmann) |
| |
| Abstract: | Within 5 weeks in 2021, B.1.1.7 became the dominant severe acute respiratory syndrome coronavirus 2 lineage at an outpatient testing site in Berlin, Germany. Compared with outpatients with wild-type virus infection, patients with B.1.1.7 had similar cycle threshold values, more frequent sore throat and travel history, and less frequent anosmia/ageusia. |
| |
| Keywords: | COVID-19 coronavirus disease SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 viruses respiratory infections zoonoses B.1.1.7 Berlin Germany viral load |
|
|
